reports
Iovance Biotherapeutics to Present at Upcoming Conferences
Iovance Biotherapeutics to Present at Upcoming Conferences SAN CARLOS, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that senior leadership plans to present at the following conferences: Chardan Annual Genetic Medicines & Cell Therapy Manufacturing Summit Fireside Chat: April 30, 2024 at 2:30 p.m. ETVirtual The Citizens JMP Life Sciences ConferenceFireside Chat: Ma...
Oaktree Specialty Lending Corporation Announces Permanent Base Managem...
Oaktree Specialty Lending Corporation Announces Permanent Base Management Fee Reduction LOS ANGELES, April 30, 2024 (GLOBE NEWSWIRE) -- Oaktree Specialty Lending Corporation (NASDAQ:OCSL) (“OCSL” or the “Company”) today announced a permanent reduction in its base management fee. Effective July 1, 2024, the base management fee will be reduced to an annual rate of 1.00% from 1.50% on gross assets, including any investments made with borrowings, but excluding any cash and cash equivalents. The new base management fee will be calculated net of the base management fees that Oaktree Fund Advise...
Man Group PLC : Form 8.3 - Tyman plc
Man Group PLC : Form 8.3 - Tyman plc FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form...
Crawford United Corporation Announces First Quarter 2024 Results
Crawford United Corporation Announces First Quarter 2024 Results Sales of $38.4 million for the quarter$4.6 million sequential increase in sales from prior quarterNet income of $3.0 million Earnings per share of $0.85 EBITDA As Defined1 of $6.7 million CLEVELAND, April 30, 2024 (GLOBE NEWSWIRE) -- Crawford United Corporation (OTC: CRAWA), a growth-oriented holding company serving diverse markets, today reported results for the quarter ended March 31, 2024. For the quarter ended March 31, 2024, sales were $38.4 million compared with $39.5 million in the same period in 2023, a decre...
- ABGSC Financials Research
- Jan Erik Gjerland
- Magnus Andersson
- Patrik Brattelius
H World Group Limited Announces Completion of the Put Right Offer for ...
H World Group Limited Announces Completion of the Put Right Offer for Its 3.00% Convertible Senior Notes due 2026 SHANGHAI, China, April 30, 2024 (GLOBE NEWSWIRE) -- H World Group Limited (Nasdaq: HTHT and HKEx: 1179, the “Company” or “H World”), a key player in the global hotel industry, today announced that it has completed its previously announced put right offer relating to its 3.00% Convertible Senior Notes due 2026 (CUSIP No. 44332NAB2) (the “Notes”). The put right offer expired at 5:00 p.m., New York City time, on Monday, April 29, 2024. Based on information from Wilmington Trust, ...
Armstrong World Industries Reports Record-Setting First-Quarter 2024 R...
LANCASTER, Pa.--(BUSINESS WIRE)-- Armstrong World Industries, Inc. (NYSE:AWI), a leader in the design, innovation and manufacture of ceiling and wall solutions in the Americas, today reported record first-quarter 2024 financial results highlighted by solid sales growth and strong operational performance driving operating income and adjusted EBITDA margin expansion. “The record results we delivered this quarter reflect the resilience of our business model and the momentum we carried into the year. The ability to drive sales and earnings growth with margin expansion while facing choppy, uncert...
The U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (...
ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that the FDA has approved a label update for LUPKYNIS. The updated label no longer includes language indicating that the safety and efficacy of LUPKYNIS has not been established beyond one year. The label now includes three-year data from the AURORA 2 double-blind, placebo-controlled extension study, which assessed the long-term safety and tolerability of LUPKYNIS in combination with mycophenolate mofetil (MMF) and low-dose glucocorticoids, compared with MM...
Total voting rights
Total voting rights 30 APRIL 2024 NORTHERN VENTURE TRUST PLC TOTAL VOTING RIGHTS In conformity with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules (the “DTRs”), Northern Venture Trust PLC (“the Company”) notifies the market that the capital of the Company as at 30 April 2024 consists of 202,695,185 ordinary shares with a nominal value of 25p each. All the ordinary shares have voting rights. The Company does not hold any ordinary shares in treasury. The total number of voting rights in the Company is therefore 202,695,185 (“the Figure”). The Figure may be use...
Total voting rights
Total voting rights 30 APRIL 2024 NORTHERN 2 VCT PLC TOTAL VOTING RIGHTS In conformity with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules (the “DTRs”), Northern 2 VCT PLC (the “Company”) notifies the market that the capital of the Company as at 30 April 2024 consists of 226,051,775 ordinary shares with a nominal value of 5p each. All the ordinary shares have voting rights. The Company does not hold any ordinary shares in treasury. The total number of voting rights in the Company is therefore 226,051,775 (“the Figure”). The Figure may be used by a sharehol...
Total voting rights
Total voting rights 30 APRIL 2024 NORTHERN 3 VCT PLC TOTAL VOTING RIGHTS In conformity with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules (the “DTRs”), Northern 3 VCT PLC (the “Company”) notifies the market that the capital of the Company as at 30 April 2024 consists of 148,866,667 ordinary shares with a nominal value of 5p each. All the ordinary shares have voting rights. The Company does not hold any ordinary shares in treasury. The total number of voting rights in the Company is therefore 148,866,667 (“the Figure”). The Figure may be used by a shareho...
Oaktree Specialty Lending Corporation Announces Second Fiscal Quarter ...
Oaktree Specialty Lending Corporation Announces Second Fiscal Quarter 2024 Financial Results and Declares Quarterly Distribution of $0.55 Per Share Announces Permanent Management Fee Reduction LOS ANGELES, April 30, 2024 (GLOBE NEWSWIRE) -- Oaktree Specialty Lending Corporation (NASDAQ: OCSL) (“Oaktree Specialty Lending” or the “Company”), a specialty finance company, today announced its financial results for the fiscal quarter ended March 31, 2024. Financial Highlights for the Quarter Ended March 31, 2024 Total investment income was $94.0 million ($1.18 per share) for the second fis...
Tryg A/S – total number of voting rights and capital
Tryg A/S – total number of voting rights and capital With reference to section 32 of the Danish Capital Markets Act (Kapitalmarkedsloven), Tryghereby publishes the company's total number of voting rights and the total share capital. After the capital decrease registered on 29 April 2024 the company's share capital was reduced by nominal DKK 92,214,355 to nominal DKK 3,081,960,545. Tryg's nominal share capital amounts to DKK 3,081,960,545 equivalent to 616.392.109 shares and 308,196,054,500 voting rights as of 30 April 2024. Attachment
Decisions of the General Meeting of Shareholders in 2024 april 30
Decisions of the General Meeting of Shareholders in 2024 april 30 AB Utenos trikotažas (the “Company”), issues on the agenda of the ordinary general meeting of shareholders, actions taken and decisions made : 1. Consolidated annual report of the Company for 2023. Consolidated annual report of the Company for the year of 2023 prepared by the Company, assessed by the auditor and approved by the Management Board was presented. No decision is taken on this item on the agenda. 2. Independent auditor's report on the set of Company’s and consolidated financial statements and consoli...
CNH kicks off A Sustainable Year series with a focus on AI
CNH kicks off A Sustainable Year series with a focus on AI CNH kicks off A Sustainable Year series with a focus on AI Basildon, April 30, 2024 Today, CNH announces the first in a series of stories to be featured in its latest A Sustainable Year magazine. The annual publication promotes the company’s innovation and sustainability initiatives. The first story explains how humans can learn to trust the recommendations of artificial intelligence (AI). AI has broad manufacturing applications that can increase efficiency and productivity, so it is important to understand how it arr...
Gentherm Reports 2024 First Quarter Results
Gentherm Reports 2024 First Quarter Results Achieved 86% Year over Year Growth in Net IncomeSecured $530M of Automotive New Business AwardsReaffirms 2024 Guidance NORTHVILLE, Mich., April 30, 2024 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced its financial results for the first quarter ending March 31, 2024. First Quarter Highlights Product revenues of $356.0 million decreased 2.1% from $36...
Avricore Health Corporate Update and Audited Results for 2023
Avricore Health Corporate Update and Audited Results for 2023 VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to announce its audited results for 2023. The Company nearly doubled its previous record revenues to $3,485,147 while gross profit increased by 163% to $1,203,396. The Company is currently in an early scale-up and growth period, and therefore has made substantial capital investments with on-hand cash during this period, and yet strong gross margins have allowed the...
Comstock Announces First Quarter 2024 Results and Corporate Updates
Comstock Announces First Quarter 2024 Results and Corporate Updates Commissions First Metal Recycling Facility, Receives Initial Revenues Demonstrating Strong Demand VIRGINIA CITY, Nev., April 30, 2024 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) (“Comstock,” “our,” and the “Company”), today announced its first quarter 2024 results, business updates and an updated 2024 business outlook. “We are pushing the boundaries of technology and sustainability, especially in metals, fuels, and artificial intelligence, by leveraging our technical bench, our diverse and growing technology portfol...
Swvl Records $3.1m Net Profit, 13% Net Margin, and an Eightfold Growth...
Swvl Records $3.1m Net Profit, 13% Net Margin, and an Eightfold Growth in Gross Profit 8x Gross Profit growth year on year to $4.1 million Achieved cash flow positivity, with self-funded growth Profitable growth drove earnings per share from continuing operations to $0.61 Strong balance sheet with no debt and more than doubled the positive equity value compared to 2022 DUBAI, United Arab Emirates, April 30, 2024 (GLOBE NEWSWIRE) -- Swvl Holdings Corp (“Swvl” or the “Company”) (Nasdaq: SWVL), a technology provider for enterprise and government mobility solutions with a global f...
Zymeworks Announces Participation in Upcoming Investor Conferences
Zymeworks Announces Participation in Upcoming Investor Conferences VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will participate in the following upcoming investor conferences: Bank of America Securities Health Care Conference: Zymeworks’ management will participate in one-on-one meetings on May 15th in Las Vegas, NV.J.P. Morgan Biote...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.